4.5 Article

Serum cytokine and chemokine profiles in patients with myasthenia gravis

Related references

Note: Only part of the references are listed.
Article Immunology

Expression of Interleukin-22 in Myasthenia Gravis

S. Zheng et al.

SCANDINAVIAN JOURNAL OF IMMUNOLOGY (2013)

Review Allergy

T-cell Subset Regulation in Atopy

Marek Jutel et al.

CURRENT ALLERGY AND ASTHMA REPORTS (2011)

Article Clinical Neurology

INCREASED SERUM INTERLEUKIN-17 LEVELS IN PATIENTS WITH MYASTHENIA GRAVIS

Jose C. Roche et al.

MUSCLE & NERVE (2011)

Article Clinical Neurology

Cytokine and chemokine profiles in neuromyelitis optica: significance of interleukin-6

Akiyuki Uzawa et al.

MULTIPLE SCLEROSIS JOURNAL (2010)

Article Clinical Neurology

CCL21 Overexpressed on Lymphatic Vessels Drives Thymic Hyperplasia in Myasthenia

Sonia Berrih-Aknin et al.

ANNALS OF NEUROLOGY (2009)

Review Pharmacology & Pharmacy

Interleukin-15: a new cytokine target for the treatment of inflammatory diseases

IB McInnes et al.

CURRENT OPINION IN PHARMACOLOGY (2004)

Article Immunology

Dendritic cell-derived IL-15 controls the induction of CD8 T cell immune responses

R Ruckert et al.

EUROPEAN JOURNAL OF IMMUNOLOGY (2003)

Article Medicine, Research & Experimental

Resolution of psoriasis upon blockade of IL-15 biological activity in a xenograft mouse model

LS Villadsen et al.

JOURNAL OF CLINICAL INVESTIGATION (2003)

Review Clinical Neurology

Myasthenia gravis - Recommendations for clinical research standards

A Jaretzki et al.

NEUROLOGY (2000)